Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CEFPODOXIME PROXETIL

CEFPODOXIME PROXETIL

Standard Dose
EQ 50MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CEFPODOXIME PROXETIL is listed in Drugs@FDA under application 090031 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFPODOXIME PROXETIL Form and strength FOR SUSPENSION;ORAL - EQ 50MG BASE/5ML Sponsor CHARTWELL RX Submission history Latest submission status date: 2014-06-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFPODOXIME PROXETIL is listed in Drugs@FDA under application 090031 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFPODOXIME PROXETIL Form and strength FOR SUSPENSION;ORAL - EQ 50MG BASE/5ML Sponsor CHARTWELL RX Submission history Latest submission status date: 2014-06-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.